CXCR4 in Cancer and Its Regulation by PPARgamma.
Chemokines are peptide mediators involved in normal development, hematopoietic and immune regulation, wound healing, and inflammation. Among the chemokines is CXCL12, which binds principally to its receptor CXCR4 and regulates leukocyte precursor homing to bone marrow and other sites. This role of CXCL12/CXCR4 is "commandeered" by cancer cells to facilitate the spread of CXCR4-bearing tumor cells to tissues with high CXCL12 concentrations. High CXCR4 expression by cancer cells predisposes to aggressive spread and metastasis and ultimately to poor patient outcomes. As well as being useful as a marker for disease progression, CXCR4 is a potential target for anticancer therapies. It is possible to interfere directly with the CXCL12:CXCR4 axis using peptide or small-molecular-weight antagonists. A further opportunity is offered by promoting strategies that downregulate CXCR4 pathways: CXCR4 expression in the tumor microenvironment is modulated by factors such as hypoxia, nucleosides, and eicosanoids. Another promising approach is through targeting PPAR to suppress CXCR4 expression. Endogenous PPARgamma such as 15-deoxy-Delta(12,14)-PGJ(2) and synthetic agonists such as the thiazolidinediones both cause downregulation of CXCR4 mRNA and receptor. Adjuvant therapy using PPARgamma agonists may, by stimulating PPARgamma-dependent downregulation of CXCR4 on cancer cells, slow the rate of metastasis and impact beneficially on disease progression.
Richard
Cynthia Lee
CL
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 1X5.
Blay
Jonathan
J
Biochem Biophys Res Commun. 2004 Jul 16;320(1):226-32
15207725
Am J Respir Cell Mol Biol. 2004 May;30(5):671-7
14672915
Breast Cancer Res Treat. 2004 Apr;84(3):247-50
15026622
J Virol. 1998 Jun;72(6):5035-45
9573273
Cancer Res. 2002 Oct 15;62(20):5930-8
12384559
Nat Rev Cancer. 2001 Oct;1(1):11-21
11900248
Lab Invest. 2007 Aug;87(8):807-17
17572689
Pharmacol Rev. 2005 Jun;57(2):279-88
15914470
Biochem Biophys Res Commun. 1985 Mar 29;127(3):739-45
3857041
J Immunol. 2001 Oct 15;167(8):4747-57
11591806
Int J Cancer. 2002 May 20;99(3):386-95
11992407
Oncol Rep. 2008 Apr;19(4):993-8
18357387
J Cell Biochem. 2003 Aug 1;89(5):975-91
12874832
Gut. 1994 May;35(5):675-8
8200564
Oncology. 2006;71(3-4):204-11
17641542
Br J Cancer. 2002 Apr 22;86(8):1250-6
11953881
Breast. 2006 Aug;15(4):533-9
16239110
Semin Cancer Biol. 2004 Jun;14(3):171-9
15246052
Clin Cancer Res. 2005 Mar 1;11(5):1835-41
15756007
Br J Cancer. 2006 Jul 17;95(2):210-7
16819541
J Clin Oncol. 2005 Apr 20;23(12):2744-53
15837989
Nat Rev Drug Discov. 2003 Jul;2(7):581-7
12815382
Biochemistry. 2003 May 13;42(18):5429-37
12731885
Cancer Res. 2002 Dec 15;62(24):7203-6
12499259
Gastroenterology. 1994 Oct;107(4):1183-8
7926468
Int J Cancer. 2003 Jan 1;103(1):84-90
12455057
Oncogene. 2004 Aug 5;23(35):5958-67
15184868
Am J Physiol Cell Physiol. 2006 Sep;291(3):C433-44
16611738
Lab Invest. 2004 Dec;84(12):1666-76
15467730
Blood. 2007 Jan 15;109(2):786-91
16888090
Surg Today. 1998;28(7):740-5
9697269
Nat Genet. 2003 May;34(1):70-4
12692554
Br J Haematol. 2001 Dec;115(3):545-53
11736934
J Biol Chem. 2001 May 25;276(21):18563-9
11278747
Clin Cancer Res. 2005 Apr 1;11(7):2561-7
15814634
Cancer Res. 2005 Aug 1;65(15):6493-7
16061624
Cancer Res. 2002 Dec 15;62(24):7328-34
12499276
Clin Cancer Res. 2005 Aug 15;11(16):5686-93
16115904
Clin Cancer Res. 2005 Apr 15;11(8):2937-46
15837745
Cancer Res. 2004 Dec 1;64(23):8604-12
15574767
Clin Cancer Res. 2000 Sep;6(9):3530-5
10999740
Pharmacol Rev. 2000 Mar;52(1):145-76
10699158
Cancer Lett. 2002 Aug 28;182(2):175-82
12048163
Int J Cancer. 1994 Mar 15;56(6):777-82
8119765
J Biol Chem. 1995 Jun 2;270(22):12953-6
7768881
Cell Signal. 2005 Dec;17(12):1578-92
16005185
Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63
15240098
Science. 2001 Nov 30;294(5548):1871-5
11729303
Clin Exp Metastasis. 2005;22(1):39-46
16132577
Mol Cell. 2006 May 19;22(4):553-60
16713585
Nat Cell Biol. 2005 Jul;7(7):719-23
15937477
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8
14595012
Int J Cancer. 2004 Jul 10;110(5):652-9
15146553
Ann Oncol. 2007 Jun;18(6):1021-9
17351259
Mol Cancer Res. 2004 Jun;2(6):327-38
15235108
Clin Cancer Res. 2005 Dec 1;11(23):8273-80
16322285
J Immunol Methods. 2005 Apr;299(1-2):177-88
15914200
Genes Dev. 2003 Feb 15;17(4):438-42
12600936
Cell. 1995 Dec 1;83(5):813-9
8521498
Cancer Res. 2004 Aug 1;64(15):5162-71
15289320
Ann Oncol. 2007 Jan;18(1):70-76
17032700
Cancer Res. 2004 Nov 15;64(22):8420-7
15548713
Cancer Res. 2005 Jun 1;65(11):4496-9
15930264
Clin Cancer Res. 2004 Dec 15;10(24):8465-71
15623626
Cancer Lett. 2007 Aug 8;253(1):34-42
17306924
Int J Gastrointest Cancer. 2006;37(4):110-9
18175225
Blood. 2001 Jan 15;97(2):346-51
11154207
Biochem Biophys Res Commun. 2007 Nov 23;363(3):542-6
17889832
J Biol Chem. 2002 May 31;277(22):19649-57
11877444
J Biol Chem. 2005 Feb 4;280(5):3217-23
15542609
Cancer Cell. 2004 Nov;6(5):459-69
15542430
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18117-22
15608062
Blood. 2002 Oct 1;100(7):2597-606
12239174
Int J Cancer. 2006 Nov 1;119(9):2026-9
16671092
J Immunol. 1987 May 15;138(10):3094-9
3106472
Transplant Proc. 2007 Jan-Feb;39(1):268-72
17275519
Blood. 2005 Feb 15;105(4):1750-8
15498850
J Biol Chem. 1998 Dec 4;273(49):32679-84
9830009
Cancer Res. 2004 Apr 1;64(7):2534-43
15059909
Annu Rev Immunol. 2001;19:397-421
11244042
J Exp Med. 2003 Nov 3;198(9):1391-402
14597738
Breast Cancer Res. 2003;5(5):R144-50
12927045
Biochem Biophys Res Commun. 2005 Sep 30;335(3):684-9
16084489
Int J Oncol. 2007 May;30(5):1215-22
17390024
J Clin Endocrinol Metab. 2003 Jan;88(1):408-16
12519884
Breast Cancer Res Treat. 2006 Jun;97(3):275-83
16344916
Cancer Res. 2002 Nov 1;62(21):6304-11
12414661
Clin Cancer Res. 2005 Jul 1;11(13):4658-65
16000558
Biochem Biophys Res Commun. 2005 Sep 23;335(2):523-8
16084492
Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):591-6
14688410
Biochim Biophys Acta. 1995 Sep 14;1258(2):215-23
7548186
Exp Cell Res. 2003 Oct 1;289(2):265-74
14499627
Am J Pathol. 1999 Apr;154(4):1125-35
10233851
Cell Tissue Res. 2007 Nov;330(2):221-9
17846797
Cancer Metastasis Rev. 2007 Dec;26(3-4):635-43
17717635
Biochem Biophys Res Commun. 2007 Aug 3;359(3):716-22
17559806
Ann Oncol. 2004 Apr;15(4):613-7
15033669
Blood. 2002 Aug 1;100(3):1100-1
12150154
Clin Cancer Res. 2003 May;9(5):1604-10
12738712
Eur J Cancer. 2008 May;44(7):1022-9
18375114
Nature. 2003 Sep 18;425(6955):307-11
13679920
Mod Pathol. 2006 May;19(5):738-45
16528367
Cancer Res. 2002 Mar 15;62(6):1832-7
11912162
Biochem Mol Biol Int. 1998 Nov;46(4):643-56
9844724
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4816-20
8643486
J Biol Chem. 2002 Mar 22;277(12):10459-66
11786541
Nature. 1996 Aug 29;382(6594):833-5
8752281
Cancer Sci. 2008 Mar;99(3):539-42
18201276
J Biol Chem. 1983 Oct 10;258(19):11713-8
6578214
Eicosanoids. 1991;4(4):203-7
1789996
Nature. 1998 Jun 11;393(6685):591-4
9634237
Nat Med. 2002 Mar;8(3):289-93
11875501
Ann N Y Acad Sci. 2002 Nov;973:60-9
12485835
Neurosurgery. 2007 Sep;61(3):570-8; discussion 578-9
17881971
Diabetes. 2000 Apr;49(4):539-47
10871190
Am J Pathol. 2004 Jul;165(1):319-30
15215186
Semin Cancer Biol. 2005 Oct;15(5):378-86
15975825
Cancer Res. 2003 Jul 1;63(13):3833-9
12839981
J Biol Chem. 1994 Jan 7;269(1):232-7
8276799
Gastroenterology. 2005 May;128(5):1445-61
15887126
J Clin Endocrinol Metab. 2005 Jun;90(6):3534-43
15755849
Nature. 1998 Jun 11;393(6685):595-9
9634238
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):16961-6
16287976
Carcinogenesis. 2008 Aug;29(8):1483-92
18310089
Lab Invest. 2006 Dec;86(12):1221-32
17075581
Clin Pharmacol Ther. 2005 May;77(5):427-36
15900288
Cancer Res. 2006 Feb 15;66(4):2181-7
16489019
J Biol Chem. 1998 Feb 20;273(8):4754-60
9468539
Ann Oncol. 2006 Jun;17(6):945-51
16627550
Cancer Res. 2005 Jul 15;65(14):6189-98
16024620
Cancer Immunol Immunother. 2006 Jun;55(6):639-43
16155757
Cell Stem Cell. 2007 Sep 13;1(3):313-23
18371365
Cancer Res. 2004 Jun 15;64(12):4302-8
15205345
Nature. 1996 Aug 15;382(6592):635-8
8757135
Science. 1996 May 10;272(5263):872-7
8629022
Nature. 2000 Jan 6;403(6765):103-8
10638762
J Lab Clin Med. 1993 Nov;122(5):518-23
8228569
Cancer Res. 2005 Nov 15;65(22):10355-62
16288025
Gut. 1999 Nov;45(5):730-2
10517910
Leukemia. 1999 Dec;13(12):1954-9
10602415
Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):364-74
11111830
FEBS Lett. 1998 Apr 17;426(2):271-8
9599023
J Clin Oncol. 2004 Mar 15;22(6):1095-102
15020611
Gut. 2002 May;50(5):658-64
11950812
Exp Cell Res. 2007 Oct 1;313(16):3446-58
17707368
Ann Surg Oncol. 2008 Jan;15(1):281-5
17763975
Cancer Res. 2003 Oct 15;63(20):6751-7
14583470
Carcinogenesis. 1999 Oct;20(10):1905-11
10506103
Cancer Res. 1997 Jul 1;57(13):2602-5
9205063
Genomics. 1995 Aug 10;28(3):495-500
7490086
Antimicrob Agents Chemother. 2000 Jun;44(6):1667-73
10817726
Gastroenterology. 1998 Nov;115(5):1049-55
9797355
J Cell Biochem. 2003 Jun 1;89(3):462-73
12761880
Anticancer Res. 1998 Sep-Oct;18(5A):3283-7
9858896
Cancer Immunol Immunother. 2005 Aug;54(8):781-91
15592929
Annu Rev Pharmacol Toxicol. 2002;42:55-80
11807164
Biochemistry. 2002 May 28;41(21):6640-50
12022867
Cancer Metastasis Rev. 2006 Sep;25(3):409-16
16951987
Cancer Res. 2005 Mar 1;65(5):1822-9
15753380
FASEB J. 2007 Oct;21(12):3219-30
17522382
Jpn J Cancer Res. 1999 Jan;90(1):75-80
10076568
Cell. 1995 Dec 1;83(5):803-12
8521497
J Cutan Pathol. 2008 Jul;35(7):623-9
18312436
Clin Cancer Res. 2006 May 1;12(9):2795-803
16675573
Carcinogenesis. 1998 Jan;19(1):49-53
9472692
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10990-5
10984506
Biochem Biophys Res Commun. 2006 Jul 21;346(1):252-8
16756955
Stem Cells. 2005 Aug;23(7):879-94
15888687
J Surg Oncol. 1998 Oct;69(2):99-104
9808513
Semin Radiat Oncol. 2004 Jul;14(3):198-206
15254862
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4844-9
10781090
Oncogene. 2005 Jun 23;24(27):4462-71
15806155
FEBS Lett. 2003 Aug 28;550(1-3):79-83
12935890
Transfusion. 2005 Mar;45(3):295-300
15752146
Int J Cancer. 2006 Nov 1;119(9):2044-53
16823836
J Clin Invest. 1999 Oct;104(8):1061-9
10525044
Cancer Res. 2002 Jun 1;62(11):3106-12
12036921
J Biol Chem. 2005 Oct 21;280(42):35760-6
16107333
Breast. 2005 Oct;14(5):360-7
16216737
Cancer Biol Ther. 2007 Jul;6(7):1018-24
17611402
J Natl Cancer Inst. 2005 Dec 21;97(24):1840-7
16368946
Cancer Res. 2005 Jan 15;65(2):465-72
15695388
Mol Cancer Ther. 2007 Oct;6(10):2609-17
17938257
Cancer Res. 2005 Feb 1;65(3):967-71
15705897
Cancer Lett. 2003 Mar 10;191(2):203-9
12618334
Eur J Cancer. 1996 Sep;32A(10):1781-7
8983290
Chin Med J (Engl). 2007 Jul 20;120(14):1251-5
17697577
FASEB J. 2004 Aug;18(11):1240-2
15180966
Cancer Gene Ther. 2005 Jan;12(1):84-9
15472715
Cancer Res. 2001 Jul 1;61(13):4961-5
11431324
J Clin Invest. 2001 Jul;108(2):269-77
11457880
J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1253-62
15385732
Nat Rev Cancer. 2004 Jan;4(1):71-8
14708027
Gynecol Oncol. 2006 Oct;103(1):226-33
16631235
J Immunol. 2001 Feb 15;166(4):2695-704
11160334
Cancer Lett. 2006 May 8;236(1):39-45
15967572
Nature. 1996 Aug 29;382(6594):829-33
8752280
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8806-11
9671760
J Biol Chem. 2005 Apr 8;280(14):14145-53
15695504
Nature. 2001 Mar 1;410(6824):50-6
11242036
J Biol Chem. 2001 Nov 30;276(48):45098-105
11571298
Stem Cells. 2001;19(5):453-66
11553854
Dig Dis Sci. 1998 Feb;43(2):311-6
9512123
Cancer Res. 2008 Mar 15;68(6):1889-95
18339870
J Exp Med. 1997 Jan 6;185(1):111-20
8996247
Biochemistry. 2004 Mar 2;43(8):2345-52
14979731
Cancer Res. 2007 Aug 1;67(15):7518-24
17671223
Cancer Res. 2005 Jul 1;65(13):5864-71
15994964
Annu Rev Immunol. 2000;18:217-42
10837058
Clin Cancer Res. 2005 Mar 1;11(5):1743-50
15755995
Gastroenterology. 1999 Aug;117(2):359-67
10419917
Int J Cancer. 2007 Sep 1;121(5):1036-46
17450528
Pharmacol Res. 2005 Feb;51(2):85-94
15629253
Nat Med. 1997 Oct;3(10):1110-6
9334722
World J Gastroenterol. 2008 Apr 21;14(15):2308-13
18416455
Cancer Res. 2003 Mar 1;63(5):958-64
12615709
Blood. 2005 Sep 1;106(5):1867-74
15890685
J Biol Chem. 2002 Dec 20;277(51):49481-7
12388552